Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study. [electronic resource]
Producer: 20170711Description: 2671-2679 p. digitalISSN:- 2326-5205
- Adalimumab -- therapeutic use
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Blood Sedimentation
- C-Reactive Protein -- immunology
- Cohort Studies
- Deprescriptions
- Drug Therapy, Combination
- Etanercept -- therapeutic use
- Female
- Humans
- Infliximab -- therapeutic use
- Male
- Middle Aged
- Pain Measurement
- Prospective Studies
- Spondylarthritis -- drug therapy
- Spondylarthropathies -- drug therapy
- Time Factors
- Tumor Necrosis Factor-alpha -- adverse effects
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.